AWARDDEFINITIVE CONTRACTOther than small business
Definitive contract 75D30120C08021QUEST DIAGNOSTICS INCORPORATED
Overview
Award facts
- Net obligations
- $709.33K
- $709,330of $728K potential value
- Outlays (paid to date)
- $709.33K
- $709.33K paid of $709.33K obligated$709,330
- Period of performance
- Apr 27, 2020 to Apr 26, 2021
- Ended
- Modifications
- 4
- Latest action Aug 29, 2023
- Contract type
- Definitive contract
- PIID 75D30120C08021
Contract value is the most the government could spend; obligations are what it has legally committed; outlays are what it has actually paid.
Description of requirement
DE-IDENTIFIED SPECIMEN REMNANTS FOR NCIRD
Dates and value
- Award date
- Signed on Apr 26, 2020
- Potential end of performance
- Apr 25, 2021
- Current value
- $728,000Base and exercised options
- Potential value (if all options are exercised)
- $728,000
Obligations by fiscal year of action
- FY2023: -$18,670 (de-obligation)
- FY2020: $728,000
Total across 2 fiscal years: $709,330
Net de-obligation in that fiscal year (obligations withdrawn).
Source: Federal Procurement Data System contract actions as published by SAM.gov and USAspending.gov; latest action recorded Aug 29, 2023. View on USAspending · Recipient on SAM.gov
Recipient
LocationBALTIMORE, MD
UEIGLPMEN5F8LZ1
CAGE code1QKM7
Business sizeOther than small businessSize at award, per the contracting officer
Organization typeCorporate not tax exempt
Parent companyQUEST DIAGNOSTICS INCORPORATED
Business types and certifications
For-profit organizationCorporation (not tax-exempt)
As represented in SAM.gov at the time of the action.
Agency and place
Awarding and funding
- Awarded by
- Department of Health and Human Services
- Centers For Disease Control And Prevention
- CDC OFFICE OF ACQUISITION SERVICES
- Funded by
- Department of Health and Human Services
- Centers For Disease Control And Prevention
- CDC OFFICE OF ACQUISITION SERVICES
- Funded from
- Cdc wide activities and program support (0943)Program activities075-0943Federal accounts (agency financial reports)
Place of performance
- Place of performance
- Atlanta, Dekalb County, Georgia 30329-4018
- Congressional district (place of performance)
- GA-05As reported at the time of the action
Classification and competition
Classification
- Product or service (PSC)
- 6505DRUGS AND BIOLOGICALS (product)
Competition
- Extent competed
- Not competedC
- Reason not competed
- Urgency (FAR 6.302-2)URG
- Solicitation procedures
- Only one sourceSSS
- Set-aside
- No set-aside used
- Contract pricing
- Firm fixed priceJ
- Offers received
- 1
Solicitation and notices
- Solicitation ID
- 75D30120Q71687(as reported)
- Solicitation date
- Apr 21, 2020
Contract details
- Subcontracting plan
- Plan not requiredB
- Cost Accounting Standards clause
- No - CAS waiver approvedN
- Certified cost or pricing data
- No
- Service Contract Act labor standards
- No
- Commercial procedures
- Commercial products/servicesA
- Government-furnished property
- Transaction does not use GFE/GFPN
- Bundled requirement
- Not bundledH
- Consolidated requirement
- Not consolidatedD
- Undefinitized action (terms not final)
- No
- Multi-year contract
- No
Transaction history
Modification history
- Base award
- Apr 26, 2020Base obligation at award: $126,000
- Latest action
- Aug 29, 2023 — Supplemental agreement (within scope)Modification P00004; obligation change -$18,670
- Latest substantive action
- Aug 29, 2023 — Supplemental agreement (within scope)Modification P00004; obligation change -$18,670
- Latest funding action
- Aug 19, 2020 — Funding onlyModification P00001; obligation change +$602,000; funding only: changes obligations, not scope
- Actions by type
- Base award1
- Other administrative action2
- Supplemental agreement (within scope)1
- Funding only1
All contract data
All contract data
Every other field reported for this award, as of its latest reported action
Competition
- Evaluation preference
- No preference used
- Local area set-aside
- No
- Synopsized publicly (SAM.gov / FedBizOpps)
- No
- Simplified procedures for commercial items
- No
- A-76 (FAIR Act) action
- No
Pricing and financing
- Paid by purchase card
- No
Socio-economic and policy
- Recovered materials and sustainability
- No clauses included and no sustainability includedC
- EPA-designated product
- Not requiredE
- Clinger-Cohen Act planning (IT)
- No
- Contingency, humanitarian or peacekeeping operation
- Presidential issued emergency declaration, or a major disaster declarationC
- Walsh-Healey Act (materials and supplies)
- No
- Construction wage rates (Davis-Bacon)
- No
Place and origin
- Domestic or foreign entity
- U.S. owned businessA
- Country of product or service origin
- United statesUSA
- Place of manufacture
- Mfg in U.S.D
Structure
- Award or IDV
- Award
- Award type
- Definitive contractD
- Awarding agency code
- 7500
- Awarding sub-tier code
- 7523
- Contracting office code
- 75D301
- Transactions recorded under this award key
- 5
Funding
- Funding agency code
- 7500
- Funding sub-tier code
- 7523
- Funding office code
- 75D301
- Treasury accounts
- 075-2020/2022-0943-000
- 075-2020/2024-0943-000
- 075-X-0943-000
- Object classes
- 26.0: Supplies and materials
- Disaster or emergency funding (DEFC)
- L: Emergency P.L. 116-123
- N: Emergency P.L. 116-136
- P: Emergency P.L. 116-139
- COVID-19 supplemental obligations
- $709,330
- COVID-19 supplemental outlays
- $709,330